ImmunityBio investigational therapy

· ImmunityBio, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ImmunityBio investigational therapy, covering 2024-06-13 to 2024-06-13. Get the full timeline:

Most recent: Clinical Trial Update: Phase 3 Study to Treat Patients With Soft Tissue Sarcomas [Phase 3]